AGA Medical litigation
This article was originally published in The Gray Sheet
Executive Summary
Amplatzer manufacturer announces a resolution of litigation between its two shareholders, July 29. Under the agreement, Franck Gougeon assumes CEO and majority shareholder roles. Former HHS Secretary Tommy Thompson will be board chairman and inventor Kurt Amplatz returns to the firm as a board member. Private equity investor Welsh, Carson, Anderson & Stowe - which formerly backed Gougeon's bid to purchase the remaining half of AGA - has taken a "significant" ownership position (1"The Gray Sheet" May 9, 2005, p. 7). Although it is operating under an FDA application integrity policy, AGA says it will continue its RESPECT clinical trial of its patent foramen ovale occlusion device for prevention of recurrent strokes...